INFO & CONTACTS:  +39 02 2390 1

EPIGENETICS IN SCLC TO EARLY DETECT TREATMENT RESISTANCE AND DISCOVERY NEW DRUGGABLE PATHWAYS

Funding Organization: Bando per la Ricerca Istituzionale

Principal Investigator: Dott.ssa Beninato Teresa

Start date:

End date:

Main Facility: EPIGENETICS IN SCLC TO EARLY DETECT TREATMENT RESISTANCE AND DISCOVERY NEW DRUGGABLE PATHWAYS

Study on the influence of epigenetic modifications on tumor immunogenicity and response to first-line chemo-immunotherapy treatment in patients with small cell lung cancer.

Principal Investigator Dr. Beninato Teresa

Dr, PhD De Cecco Loris

Dr. Prelaj Arsela

Integrated Biology of Rare Tumors
Research Area, Departmental Simple Structure

Last update: 26/05/2025

Subscribe to the newsletter

Sign up for our newsletter to stay informed about news, events, and updates from the Institute

Subscribe